Anti‐prolactin treatment alleviates lupus conditions by regulating the JAK2–STAT3 pathway

New insights into the role of antinuclear antibodies in systemic lupus erythematosus

(2020) David S. Pisetsky et al.   Nature Reviews Rheumatology

Prolactin and autoimmunity: The hormone as an inflammatory cytokine

(2019) Vânia Vieira Borba et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Prolactin and Autoimmunity

(2018) Vânia Vieira Borba et al.   Frontiers in Immunology

Systemic lupus erythematosus: Diagnosis and clinical management

(2018) Andrea Fava et al.   JOURNAL OF AUTOIMMUNITY

Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus

(2018) L. Pacheco-Lugo et al.   LUPUS

Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist

(2017) Huanzhong cui et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity

(2017) Tanvi Arkatkar et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus

(2017) Jin-Young Choi et al.   JOURNAL OF IMMUNOLOGY

Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody–Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers

(2017) Marcus P. Kelly et al.   MOLECULAR CANCER THERAPEUTICS

The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus

(2016) Aleš Goropevšek et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Prolactin: A versatile regulator of inflammation and autoimmune pathology

(2015) Massimo Costanza et al.   AUTOIMMUNITY REVIEWS

A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice

(2015) Christiane Otto et al.   ENDOCRINOLOGY

The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications

(2015) Vincent Goffin et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus

(2015) J Yang et al.   LUPUS

The Effects of Bromocriptine on Preventing Postpartum Flare in Systemic Lupus Erythematosus Patients from South China

(2015) Qiu Qian et al.   Journal of Immunology Research

Transcriptional and epigenetic regulation of T-helper lineage specification

(2014) Subhash K. Tripathi et al.   IMMUNOLOGICAL REVIEWS

Increased IL-17 and IL-21 producing TCRαβ+CD4−CD8− T cells in Chinese systemic lupus erythematosus patients

(2014) H-X Wang et al.   LUPUS

Molecular Pathways: Blockade of the PRLR Signaling Pathway as a Novel Antihormonal Approach for the Treatment of Breast and Prostate Cancer

(2013) J. S. Damiano et al.   CLINICAL CANCER RESEARCH

Diagnosis and treatment of lupus nephritis flares—an update

(2012) Ben Sprangers et al.   Nature Reviews Nephrology

Prolactin and Autoimmunity

(2011) Hedi Orbach et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

(2011) L. D. Lu et al.   JOURNAL OF IMMUNOLOGY

Prolactin, Systemic Lupus Erythematosus, and Autoreactive B Cells: Lessons Learnt from Murine Models

(2009) Subhrajit Saha et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Human TCR-  + CD4- CD8- T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype

(2009) J. C. Crispin et al.   JOURNAL OF IMMUNOLOGY